Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03140514Completed
Randomised, single-blind trial (2 arms), sponsored by University Hospital Basel. Primary endpoints: Graft loss not due to death of the patient at 1 year, Biopsy-proven clinical acute rejection at 1 year and 2 more. Started Sep 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03140514.